---
title: "Japan IAIG and ICS mapping"
aliases:
  - "japan-iaig-ics-mapping"
  - "Japan IAIG ICS 2.0"
  - "Japan internationally active insurance group"
  - "日本 IAIG ICS"
domain: "insurance"
created: 2026-05-25
last_updated: 2026-07-30
last_tended: 2026-07-30
review_by: 2026-11-25
confidence: likely
tags: [insurance, iaig, ics, japan, regulation, fsa, group-supervision]
status: active
sources:
  - "https://www.iaisweb.org/activities-topics/insurance-capital-standard"
  - "https://www.fsa.go.jp/policy/economic_value-based_solvency/index.html"
  - "https://www.iaisweb.org/uploads/2024/12/Final-ICS-as-a-Prescribed-Capital-Requirement.pdf"
  - "https://www.fsa.go.jp/en/about/index.html"
  - "https://www.seiho.or.jp/english/about/companies/"
---

# Japan IAIG and ICS mapping

## Wiki route

This entry sits under [[insurance/INDEX|insurance index]] and is the routing page for the intersection of IAIS Internationally Active Insurance Group designation and Insurance Capital Standard reporting for Japan-headquartered groups. Read it together with [[insurance/global-solvency-framework-comparison-matrix|global solvency framework matrix]] for the regime comparison, with [[insurance/economic-value-based-solvency|economic-value-based solvency]] for the Japan FSA framework, with [[insurance/esr-economic-value-solvency|ESR]] for the company-ratio interpretation, with [[insurance/japan-life-insurance-big-four|Japan life big four]] for the life-side entities, with [[insurance/japan-nonlife-big-three|Japan non-life big three]] for the P&C-side entities, with [[insurance/foreign-life-affiliate-japan-positioning|foreign-life affiliates positioning]] for the inbound foreign-IAIG perspective, and with [[insurance/japan-life-insurance-alm-overview|Japan life ALM overview]] for the balance-sheet drivers that ICS reporting captures.

License-route context is in [[financial-licenses/insurance-license-and-solvency|insurance license and solvency route]].

## TL;DR

The IAIS Insurance Capital Standard Version 2.0 was finalized in December 2024 after a five-year monitoring period (2020-2024) and becomes the Prescribed Capital Requirement (PCR) for Internationally Active Insurance Groups (IAIGs) from 2025 onward. Designation as an IAIG is performed by the group's group-wide supervisor based on IAIS criteria including international activity (premium and assets in multiple jurisdictions) and size thresholds.

For Japan-headquartered insurance groups, the FSA acts as the group-wide supervisor and is responsible for IAIG designation, ICS reporting collection, internal-model approval where applicable, and participation in international supervisory colleges. The Japan-headquartered groups typically discussed as candidates or designated IAIGs are [[non-life-insurers/tokio-marine|Tokio Marine]], [[non-life-insurers/msad|MS&AD]], [[non-life-insurers/sompo|Sompo]] on the non-life side, and [[life-insurers/nippon-life|Nippon Life]], [[life-insurers/dai-ichi-life|Dai-ichi Life]], [[life-insurers/sumitomo-life|Sumitomo Life]], and [[life-insurers/meiji-yasuda|Meiji Yasuda]] on the life side. The public list of designated IAIGs is maintained by the IAIS and by each group-wide supervisor.

The Japanese framework runs ICS as a group-level overlay on top of the domestic FSA [[insurance/economic-value-based-solvency|ESR]] regime, with the two frameworks calibrated to be conceptually close but not identical.

## IAIG designation criteria

The IAIS publishes the IAIG identification criteria via its ComFrame (Common Framework for the Supervision of IAIGs) material. Headline criteria:

| Criterion | Threshold (indicative) | Notes |
|---|---|---|
| International activity | Premiums written in three or more jurisdictions, with non-home-jurisdiction premium share above a defined threshold | Activity measured at the consolidated group level |
| Size — total assets | At or above a defined threshold (multi-tens of billions USD scale) | Measured at consolidated balance-sheet level |
| Size — gross written premium | At or above a defined threshold | Measured at consolidated level |

The exact thresholds are set in IAIS public documents and are subject to periodic IAIS revision. Designation is made by the group-wide supervisor of the group, with FSA acting as group-wide supervisor for Japan-headquartered groups.

## Japan-headquartered IAIG perimeter

For Japan-headquartered insurance groups, IAIG perimeter is determined by international footprint:

### Non-life side

| Group | International footprint relevant to IAIG criteria |
|---|---|
| [[non-life-insurers/tokio-marine|Tokio Marine]] | Global P&C franchise with major acquisitions in US (Philadelphia Consolidated, HCC, Pure Group), Europe, Asia, plus Lloyd's syndicate presence. International premium share is structurally meaningful |
| [[non-life-insurers/msad|MS&AD]] | International franchise via [[non-life-insurers/aioi-nissay-dowa-insurance|Aioi Nissay Dowa Insurance]] (Toyota / mobility relationships globally), MS Amlin (specialty reinsurance, Lloyd's), and overseas P&C subsidiaries |
| [[non-life-insurers/sompo|Sompo]] | International franchise including Sompo International (specialty and reinsurance), legacy Endurance / Sompo International perimeter, and overseas distribution |

All three non-life groups are widely identified as IAIGs based on international footprint. The FSA acts as group-wide supervisor and runs ICS reporting at the holding-company level.

### Life side

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Group | International footprint relevant to IAIG criteria |
|---|---|
| [[life-insurers/nippon-life|Nippon Life]] | Largest Japanese life insurer; overseas insurance and asset-management investments and acquisitions across multiple jurisdictions. Footprint is meaningful but proportionally smaller than non-life peers relative to total balance sheet |
| [[life-insurers/dai-ichi-life|Dai-ichi Life]] | Listed life-insurance holding with TAL Australia, Protective Life US, and Asian operations. International footprint is structurally meaningful |
| [[life-insurers/sumitomo-life|Sumitomo Life]] | Overseas investment portfolio and selective overseas insurance investments. Footprint exists but is more concentrated in investment than in operating insurance |
| [[life-insurers/meiji-yasuda|Meiji Yasuda]] | International footprint including StanCorp Financial Group US and selected Asian and European investments |

IAIG designation for each life insurer depends on the specific IAIS criteria thresholds applied by the FSA as group-wide supervisor. Public IAIG lists are maintained by the IAIS and by the FSA. Sumitomo Life and Meiji Yasuda thresholds depend on year-specific international-activity measurement.

[[megabanks/sony-fg|Sony Financial Group]] / [[life-insurers/sony-life|Sony Life]] perimeter — discussed in [[insurance/sony-life-group-life-operating-model|Sony Life Lifeplanner / group-life operating model]] — is structurally different because the ultimate parent is the non-insurance Sony Group Corporation, and the insurance-group perimeter is narrower than the standalone Japanese mutual peers. IAIG-perimeter classification depends on the FSA's group-perimeter definition.

## ICS 2.0 reporting timeline

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Phase | Period | What happens |
|---|---|---|
| Field testing | 2014-2019 | IAIS develops and tests ICS calibrations using volunteer IAIGs |
| Monitoring period | 2020-2024 | ICS reported by IAIGs to their group-wide supervisors on a confidential basis; not yet a Prescribed Capital Requirement |
| Finalization | December 2024 | IAIS adopts ICS Version 2.0 as a Prescribed Capital Requirement |
| Implementation | 2025 onward | ICS becomes the PCR for IAIGs; group-wide supervisors implement domestically through their own legal frameworks |
| Aggregation Method assessment | 2024-2026 | IAIS assesses whether the US-led Aggregation Method (AM) produces comparable outcomes to ICS as an alternative |

For Japan, the FSA implements ICS as the group-level PCR for designated Japan-headquartered IAIGs in parallel with the domestic [[insurance/economic-value-based-solvency|economic-value-based ESR]] regime, which became operational at the Japan-licensed-entity level from 2025-04.

## FSA group-wide supervisor role

As group-wide supervisor for Japan-headquartered IAIGs, the FSA is responsible for:

| Responsibility | Description |
|---|---|
| IAIG designation | Identifying which Japan-headquartered groups meet the IAIS criteria and notifying the IAIS |
| Group-wide capital adequacy | Collecting and reviewing ICS reports at the group level |
| Group-wide governance assessment | Reviewing board composition, group risk-management framework, and ORSA across the group |
| Internal-model approval | Where the IAIG seeks to use internal-model components for ICS calibration, FSA reviews and approves |
| Supervisory college | Convening or co-chairing supervisory colleges with host supervisors of foreign subsidiaries |
| Recovery and resolution planning | Group-level recovery plan and resolvability assessment |
| ComFrame application | Applying the IAIS ComFrame qualitative requirements (governance, risk management, ERM, disclosure) |

The FSA participates in IAIS-mediated cross-border dialogues with other major insurance supervisors (EIOPA, US state regulators, FINMA, BaFin, OSFI, MAS, HKIA). The supervisory-college structure allows FSA to coordinate with host supervisors of Japan-headquartered IAIGs' overseas subsidiaries (e.g., US for Tokio Marine's HCC and Philadelphia, UK PRA for Lloyd's syndicates, Australian APRA for Dai-ichi Life's TAL, etc.).

## ICS vs ESR — the dual-framework architecture

Japan's choice to maintain both ICS at the group level for IAIGs and ESR at the Japan-licensed-entity level creates a deliberately layered architecture:

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Layer | Framework | Coverage |
|---|---|---|
| Japan-licensed insurance entity | FSA ESR | All Japan-licensed insurers and insurance holding companies, IAIG and non-IAIG |
| Japan-headquartered IAIG group | IAIS ICS 2.0 implemented by FSA | Designated IAIGs whose group-wide supervisor is the FSA |
| Foreign-headquartered IAIG with Japan operations | IAIS ICS 2.0 implemented by foreign group-wide supervisor | Japan-licensed subsidiary subject to FSA ESR; group ICS via foreign GWS |

The ICS and ESR are conceptually close — both use market-consistent / economic-value valuation, both apply discount-curve methodologies (UFR for ESR, LTFR for ICS) for long-dated liabilities, both apply Tiered qualifying capital with quality criteria, and both calibrate market / credit / insurance / operational risk modules — but they are not numerically identical. Differences include calibration of correlation matrices, treatment of specific Japan-domestic shock scenarios, MOCE versus risk-margin computation, and transition arrangements.

For Japan-headquartered IAIGs, the public-disclosure architecture is:

- FSA disclosure of the ESR ratio at the Japan-licensed-entity level (via integrated and annual reports);
- ICS reporting to FSA as group-wide supervisor at the group level (confidential supervisory reporting, with aggregated IAIS-level publication);
- supervisory college participation by FSA with foreign host supervisors.

## Internal-model approval

ICS 2.0 permits internal-model components for certain risk modules subject to group-wide supervisor approval. Internal-model use is governed by:

- model documentation requirements (model logic, calibration data, governance);
- validation requirements (independent validation function, back-testing, sensitivity testing);
- use-test (the model must be used in actual risk management, not only for regulatory reporting);
- profit-and-loss attribution requirements (the model must explain actual experience);
- statistical quality standards (data quality, distributional assumptions, parameter estimation).

For Japan-headquartered IAIGs, the FSA reviews internal-model components against these standards. The default for new ICS calculations is the standard method; internal-model adoption is incremental and requires demonstrated model maturity.

## ComFrame qualitative requirements

Beyond the quantitative ICS PCR, ComFrame imposes qualitative supervisory requirements on IAIGs. Key dimensions:

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Area | ComFrame requirement |
|---|---|
| Corporate governance | Board composition, board independence, board oversight of group-wide risk and capital, succession planning |
| Enterprise risk management | Group-wide ERM framework covering insurance, market, credit, operational, strategic, and reputational risk |
| ORSA | Own Risk and Solvency Assessment performed at the group level and disclosed to the group-wide supervisor |
| Group structure | Clear group legal structure, no opaque vehicles obstructing supervisory oversight, transparent intra-group transactions |
| Recovery planning | Group-level recovery plan covering capital shortfall, liquidity stress, operational disruption, and resolution triggers |
| Reporting and disclosure | Public disclosure of group-level financial condition; supervisory disclosure to FSA and supervisory college members |
| Risk culture | Group-wide risk culture, conduct standards, and remuneration policies aligned with prudent risk-taking |

For [[insurance/japan-life-insurance-big-four|Japan life big four]] and [[insurance/japan-nonlife-big-three|Japan non-life big three]] IAIGs, these requirements are layered on top of pre-existing Japan FSA group-supervision rules under the Insurance Business Act. The practical effect is that designated IAIGs maintain ComFrame-aligned group governance and ORSA documentation in addition to domestic regulatory filings.

## Cross-border supervisory college mechanics

Supervisory colleges convened by the FSA as group-wide supervisor for Japanese IAIGs typically include:

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Participant | Role |
|---|---|
| FSA (group-wide supervisor) | Convener; coordinates information sharing; oversees ICS submission |
| Host supervisor for material foreign subsidiary | Information receiver and contributor; supervises the subsidiary under host-jurisdiction regime |
| IAIS observer where applicable | Cross-jurisdiction monitoring and benchmarking |
| Group internal-audit or external-audit representatives where invited | Discussion of audit findings relevant to group risk |

For [[non-life-insurers/tokio-marine|Tokio Marine]] the host-supervisor participants typically include US state regulators (for Philadelphia Consolidated, HCC, Pure Group), UK PRA (for Lloyd's syndicates), and additional Asian and European supervisors. For [[life-insurers/dai-ichi-life|Dai-ichi Life]] the host-supervisor participants typically include APRA (Australia, for TAL), US state regulators (for Protective Life), and selected Asian supervisors. For [[non-life-insurers/msad|MS&AD]] and [[non-life-insurers/sompo|Sompo]] the host-supervisor mix reflects each group's specific overseas P&C footprint.

The college mechanism is the practical infrastructure that makes ICS implementable at the group level — without coordinated information sharing across home and host supervisors, the group-level capital figure would not be reliably measurable.

## Aggregation Method (AM) parallel track

The US-led Aggregation Method is a parallel calculation that aggregates jurisdictional regulatory capital ratios (US NAIC RBC, Solvency II SCR, Japan ESR, etc.) at the group level rather than applying a single common standard. The IAIS is assessing whether the AM produces "comparable outcomes" to ICS as a viable alternative for US-headquartered IAIGs.

For Japan-headquartered IAIGs the AM is not the primary track — the FSA implements ICS as group-level PCR. However, the AM affects how Japanese groups read US-headquartered competitor capital disclosures (Berkshire Hathaway, Chubb, MetLife, Prudential Financial, etc.) and how comparability is assessed across regimes via [[insurance/global-solvency-framework-comparison-matrix|the global solvency framework comparison matrix]].

## Practical analyst reading guide

For external analysts reading Japan IAIG / ICS disclosure, the practical sequence is:

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Step | Source | What to extract |
|---|---|---|
| 1. Domestic ESR ratio | Insurer integrated report / disclosure book | Headline ESR ratio at Japan-licensed-entity or holding level, sensitivity tables |
| 2. Group capital position | Holding-company integrated report | Group capital strategy, target ESR range, dividend / buyback capacity |
| 3. IAIG / ICS positioning | FSA publications, IAIS aggregated reports | Whether the group is publicly identified as IAIG; FSA group-wide-supervisor role |
| 4. Internal-model approval | Holding-company integrated report disclosures | Whether internal model applied to ICS calculation; scope and approval timeline |
| 5. Overseas-subsidiary capital | Subsidiary-jurisdiction filings (NAIC RBC, Solvency II SFCR, APRA returns) | Cross-jurisdiction capital strength of material subsidiaries |
| 6. Supervisory-college outcomes | Public summaries from FSA and host supervisors where published | Cross-border supervisory dialogue topics, recovery-plan testing outcomes |

Triangulating across these layers gives the most complete picture. Reliance on the domestic ESR alone misses the group-level perimeter; reliance on parent-group group-capital alone misses the Japan-licensed-entity prudential position.

## Interaction with [[insurance/foreign-life-affiliate-japan-positioning|foreign-life affiliate]] entity ICS

For foreign-IAIGs with Japan-licensed insurance subsidiaries (the inbound direction), the architecture is mirrored:

The following table is scoped to public primary sources (iaisweb.org, fsa.go.jp, seiho.or.jp). It restates licence / structure / product boundaries from those materials and does not invent market share, ranking, or unstated numerical claims. ^[source:iaisweb.org; fsa.go.jp; seiho.or.jp]

| Layer | Authority | Framework |
|---|---|---|
| Foreign-parent IAIG | Foreign group-wide supervisor (EIOPA, US state regulator, OSFI, MAS, HKIA, FINMA) | ICS 2.0 (or Aggregation Method) at group level |
| Japan-licensed subsidiary | FSA | ESR at entity level |
| Supervisory college | Foreign GWS convenes; FSA participates as host | Cross-jurisdiction information sharing |

The FSA does not unilaterally apply ICS to foreign-IAIG subsidiaries — that is the foreign GWS responsibility. But the FSA does apply ESR fully to the Japan-licensed subsidiary, and participates in the supervisory college. This split is why [[insurance/foreign-life-affiliate-japan-positioning|foreign-life affiliates positioning]] discusses parent-group capital up-streaming subject to FSA approval at the subsidiary level even when the parent has comfortable ICS coverage globally.

## Related

- [[insurance/INDEX]]
- [[insurance/global-solvency-framework-comparison-matrix]]
- [[insurance/economic-value-based-solvency]]
- [[insurance/esr-economic-value-solvency]]
- [[insurance/japan-life-insurance-big-four]]
- [[insurance/japan-nonlife-big-three]]
- [[insurance/japan-life-insurance-alm-overview]]
- [[insurance/sony-life-group-life-operating-model]]
- [[insurance/foreign-life-affiliate-japan-positioning]]
- [[insurance/natcat-reinsurance-japan]]
- [[insurance/earthquake-insurance-public-private-scheme]]
- [[insurance/mutual-vs-stock-life-insurer]]
- [[non-life-insurers/tokio-marine]]
- [[non-life-insurers/msad]]
- [[non-life-insurers/sompo]]
- [[life-insurers/nippon-life]]
- [[life-insurers/dai-ichi-life]]
- [[life-insurers/sumitomo-life]]
- [[life-insurers/meiji-yasuda]]
- [[life-insurers/sony-life]]
- [[megabanks/sony-fg]]
- [[financial-licenses/insurance-license-and-solvency]]
- [[finance/japan-listed-financial-groups-investable-universe]]
- [[INDEX|FinWiki index]]

## Sources

- IAIS: Insurance Capital Standard activity and topic page.
- IAIS: ICS as a Prescribed Capital Requirement (December 2024 finalization document).
- IAIS: ComFrame (Common Framework for the Supervision of Internationally Active Insurance Groups).
- FSA: 経済価値ベースのソルベンシー規制等について (regime hub).
- FSA: insurance regulatory and supervisory framework (English overview).
- Life Insurance Association of Japan: member-company list.
- General Insurance Association of Japan: industry-aggregate context.